Blood centers across the country are seeing a renewed interest in whole blood transfusions. The main fuel to this fire appears to be the recent change from AABB and the forthcoming 31st edition of Standards for Blood Banks and Transfusion Services which allows for the use of low titer group O whole blood in emergent situations for recipients of unknown blood type (AABB News, 2017).Read More
Dr. Beddard is Medical Director at South Texas Blood & Tissue Center.
"5 Questions with..." is a regular series of questions and answers with blood industry thought leaders. This installment looks at Acrodose, an FDA-approved whole blood derived alternative to apheresis Single Donor Platelets. Bloodbuy is not affiliated with Haemonetics, the provider of the Acrodose system, although Acrodose products are available on the Bloodbuy platform.Read More
Imagine if street lights shut off, taps ran dry, or the internet switched off every year during the holidays. The chaos caused by disruptions in utilities would be immense. That is just what happens, though, with the nation’s blood supplyRead More
The Big Data revolution is coming to the blood banking community. Other areas of health care have gradually embraced the transformative power of large-scale data collection and analysis. The impact of this change is difficult to predict, but will almost certainly include reductions in wasted units and improvements in distribution.Read More